left-arrow right-arrow pinterest facebook google_plus linkedin

MD Anderson 2008-0118

Conservative Surgery for Women with Cervical Cancer

Status:

Recruiting | Phase II

Official Title:

Conservative Surgery for Women with Low-risk, Early Stage Cervical Cancer

Study Purpose:  

To determine if conservative surgery is a safe and reasonable option for women with early stage, low-risk cervical cancer.

Intervention:     

  • Cervical cone biopsy and an endocervical curettage (ECC), if not already done
  • Conservative Surgery = Removal of the pelvic lymph nodes and for women no longer wanting children, a simple hysterectomy (removal of the uterus)

After completion of study surgery, patients have follow ups every 3 months for 2 years, then once a year for 3 years.   

Key Participation Requirements:

Gender:

Female

Age:

19 years and older

Diagnosis:

Stage IA2 or IB1 Cervical Cancer

Cell types:

Squamous Cell Carcinoma (any grade), or Grade 1 or 2 Adenocarcinoma of the cervix

Eligibility:

Tumor size on physical exam or imaging (CT scan) must be 2 cm or less.

Cervical cone biopsy and ECC must be done within 12 weeks of registration to this study.

Patients must sign an approved informed consent and authorization permitting release of personal health information.

Methodist Health System Trial Code:

MD Anderson 2008-0118

For more information, visit the U.S. National Library of Medicine clinical trial database.

To learn more about this clinical trial please contact us today!